Jeannie Woith on the Treatment of Oral Mucositis in Patients with Head and Neck Cancer

The immunotherapy Opvido and reirradiation resulted in a one-year progression-free survival rate of 61.7% among certain patients with head and neck cancer.

CURE® editors take a look back on last week’s major oncology headlines, from the cancer drug shortage to FDA approvals and the potential benefit of sexual activity for cervical cancer survivors.

When compared with unvaccinated patients, HPV vaccines were associated with lower rates of HPV-related cancer for people younger than 40.

Bill C. Potts, author and five-time cancer survivor, lends his experience and tips about cancer to others in his book, “Up for the Fight.”

Patients with laryngeal cancer who stopped smoking before receiving treatment had better survival outcomes, compared with patients who actively smoke.

Cancer is an emotionless assassin that can attack us and the ones we love most.